Galectin Therapeutics Inc — Cash Flow (NASDAQ:GALT) | MetaTrader

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Cash from operating activities 20.6 M24.31 M31.06 M32.97 M41.8 M 30.6 M Cash from investing activities 00000 — Cash from financing activities 263 K36.81 M10 M40.03 M31.23 M 15.09 M Free cash flow 20.6 M24.31 M31.06 M32.97 M41.8 M 30.6 M

Новости

Директор Galectin Therapeutics Марк Рубин покинул совет директоров

Galectin Therapeutics director Marc Rubin resigns from board

Финансовый директор Galectin Therapeutics продал акции на $233 тыс.

Galectin Therapeutics CFO sells $233k in shares

Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains

oracle, micron tech among market cap stock movers on friday

Акции Galectin Therapeutics рухнули после отзыва FDA о препарате

Galectin Therapeutics stock plummets after FDA feedback on drug

FDA предоставила отзыв о программе разработки белапектина Galectin

FDA provides feedback on Galectin’s belapectin development program

Директор Galectin Therapeutics продал акции на сумму $1,05 млн

Акционеры Galectin Therapeutics избрали совет директоров